In the validation study , administration of GLP-2 at 7 hours after the meal , in the absence of additional food intake , robustly increased levels of TRL triglycerides ( P = .007 ) , TRL retinyl palmitate ( P = .002 ) , and TRL apoB-48 ( P = .04 ) compared with placebo .